UCSD registers Phase 2 study of low-dose dexamethasone to prevent Immunocore's tebentafusp CRSSep 3Trial updatedexamethasoneImmunocore Ltd
Immunocore posts Q2 KIMMTRAK sales growth as key melanoma trial nears enrollment targetAug 6Quarterly updateImmunocore Ltdtebentafusp
Sign inSign in